9CWV image
Deposition Date 2024-07-30
Release Date 2024-10-30
Last Version Date 2026-04-29
Entry Detail
PDB ID:
9CWV
Title:
Gag CA-SP1 immature lattice from intact enveloped virus-like particles
Biological Source:
Expression System(s):
Method Details:
Experimental Method:
Resolution:
2.42 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Gag
Gene (Uniprot):gag
Mutagens:T239I
Chain IDs:A, B (auth: C), C (auth: B), D, E, F, G, H, I, J, K, L, M, N, O, P, Q, R
Chain Length:231
Number of Molecules:18
Biological Source:Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)
Ligand Molecules
Primary Citation
Distinct Target Site of Lenacapavir in Immature HIV-1 and Concurrent Binding with the Maturation Inhibitor Bevirimat.
J.Am.Chem.Soc. 147 42685 42700 (2025)
PMID: 41198571 DOI: 10.1021/jacs.5c13735

Abstact

HIV-1 inhibitors, such as bevirimat (BVM) and lenacapavir (LEN), significantly reduce the production and maturation of infectious virions. However, their mechanisms remain unclear due to the absence of high-resolution structures for BVM in complex with the immature Gag lattice and LEN's structural data being limited to the mature capsid. Utilizing perforated virus-like particles (VLPs) produced from mammalian cells, we determined in situ cryo-electron microscopy (cryo-EM) structures of HIV-1 with inhibitors. This allowed for the first structural determination of the native immature HIV-1 particle with BVM and LEN bound inside the VLPs at high resolutions. Our findings demonstrate that LEN not only binds the mature capsid but also targets the immature lattice in a distinct manner. The binding of LEN induces a conformational change in the capsid protein (CA) region and alters the architecture of the Gag lattice, which may affect the maturation process. In addition, a more accurate model of BVM engaging the Gag lattice is revealed, one that is independent of LEN binding. These insights expand our understanding of the inhibitory mechanisms of LEN and BVM on HIV-1 and provide valuable clues for the design of future inhibitors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback